You just read:

Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency

News provided by

Sangamo Therapeutics, Inc.

Jun 07, 2017, 07:30 ET